BioCentury
ARTICLE | Politics & Policy

H.R. 3 to pass House next week, dead on arrival at Senate

December 5, 2019 4:54 PM UTC
Updated on Dec 6, 2019 at 4:18 AM UTC

The House will vote next week on H.R. 3, which has been renamed the Elijah E. Cummings Lower Drug Costs Now Act, House Democratic leaders said in a statement released Thursday.

The House is certain to pass H.R. 3, but there is little chance that it will be considered by the Senate. The legislation has nevertheless provoked strenuous debates over the effects of price controls on biomedical innovation (See “Debating the Fate of Innovation”). ...